Artivion
AORT
21.26
+0.05
+0.24%
Artivion
US · AORT
#3212 by market cap
21.26
+0.05
+0.24%
Live - 5344 symbols - heartbeat 15s ago
· 2026-10-09 19:30
About Artivion
Artivion, Inc. engages in the manufacture, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. It operates through the Medical Devices and Preservation Services segments. The Medical Devices segment includes aortic stents and stent grafts, surgical sealants, and On-X products. The Preservation Services segment offers cardiac and vascular tissue preservation services. The company was founded on January 19, 1984, and is headquartered in Kennesaw, GA.
- Founded
- 1984
- CEO
- Mr. James Patrick Mackin
- Employees
- 1,800
- Headquarters
- Kennesaw, Georgia, United States of America
- Fiscal year end
- 12-31
- Website
- artivion.com
Company profile
- Exchange
- US
- Symbol
- AORT
- Market-cap rank
- #3212
- Market cap
- 1.04B
- Float cap
- 983.83M
- Shares out
- 48.76M
- Float shares
- 46.28M
Sectors & themes
Medical Devices
Fractional Shares JP
Quote time 2026-10-09 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Artivion discussion 0 comments